Skip to main content

Despite WHO’s suspension, Brazil continues with hydroxychloroquine

Brazil’s health ministry has said it would not change its recommendation to treat coronavirus with hydroxychloroquine, despite the World Health Organization’s decision to suspend trials of the drug over safety concerns.

Like his US counterpart Donald Trump, Brazilian President Jair Bolsonaro has touted the supposed benefits of hydroxychloroquine and a related drug, chloroquine, against the new coronavirus.

Studies, however, have questioned their safety and efficacy against the disease, including one published Friday in respected medical journal The Lancet that found the drugs actually increased the risk of death.

That led the WHO to suspend a worldwide clinical trial of hydroxychloroquine as a COVID-19 treatment Monday.

“We’re remaining calm and there will be no change” to the Brazilian guideline issued last week, health ministry official Mayra Pinheiro told a news conference.

The guideline recommended doctors in the public health system prescribe either chloroquine or hydroxychloroquine from the onset of COVID-19 symptoms.

It was issued shortly after the resignation of former health minister Nelson Teich, who reportedly quit over Bolsonaro’s insistence on pushing the drugs despite a lack of solid evidence.

He was Brazil’s second health minister in less than a month.

Brazil, the Latin American country hit hardest by the pandemic, has emerged as the latest flashpoint, with nearly 375,000 cases — the second-highest in the world, after the United States — and more than 23,000 deaths.

Experts say under-testing means the real figures are probably far higher.

Hydroxychloroquine is typically used to treat autoimmune diseases, while chloroquine is generally used against malaria.

Preliminary studies in China and France had generated hope the drugs might be effective against the new coronavirus.

That led governments to buy them in bulk. Trump even said last week he was taking hydroxychloroquine as a preventive measure, though he said Sunday he had finished his course of treatment.

Pinheiro questioned the Lancet study, which analyzed the medical records of 96,000 patients across hundreds of hospitals.

“It wasn’t a clinical trial, it was just a data set collected from different countries, and that doesn’t meet the criteria of a methodologically acceptable study to serve as a reference for any country in the world, including Brazil,” she said.


Comments

Post a Comment

Popular posts from this blog

Kenyan Law Court dismisses case of man seeking compensation after his wife eloped with another man from hospital

  A lawsuit filed by a man seeking to be compensated by St Mary's Mission Hospital in Kenya for allowing his wife to leave the hospital with another man after giving birth, has been struck out by a law court.    The appellant had sued the St. Mary's Mission hospital at Kakamega law courts in 2020 seeking general damages from the facility on grounds that the hospital had discharged his wife and allowed her to leave with another man. After delivering and at the time of discharge, the wife of the appellant claimed he was the baby's father.   The court of appeal judges Patrick Kiage, Mumbi Ngugi and Francis Tuiyott sitting at the Kisumu Court of Appeal, empathized with the man, but disagreed that he (the appellant) be compensated by the hospital for not detaining his wife.  They upheld the lower court's judgement which added that there's no remedy that lies in the law for such grievances.   Kiage said;   "I agree that if a man takes the woman he loves to t...
Post a Comment
Read more

Hurricane Hits Texas, One Person Reported Dead

Hurricane Harvey hit Texas as a Category 4 storm on Friday, battering the coast with 130-mph winds and torrential rain. It was the strongest hurricane to hit the United States in more than a decade leaving a massive destruction, loss of electricity, wrecked buildings and has so far killed at least one person. Scroll down to see more pictures of the incident:
Post a Comment
Read more

Floyd Mayweather backs out of fight with 20-year-old kickboxer after receiving bashing from 50 Cent and others

American professional boxer, Floyd Mayweather, has dramatically made a U-Turn and won't be fighting 20-year-old Japanese kickboxer,Tenshin Nasukawa anymore for his comeback fight. The 41-year-old had initially confirmed the bout for 31st of December 2018 during a press conference which took place on Sunday night in Tokyo. It was also understood that he revealed that he signed with Japanese mixed martial arts promotions company RIZIN Fighting Federation. After the announcement, his enemies, 50 Cent, Conor McGregor and many others blasted him for agreeing to fight a younger kickboxer. Taking to his Instagram account this night, Mayweather denied he agreed to an official bout with Tenshin Nasukawa. He wrote:  Now that I am back on U.S. soil after a long and disappointing trip to Tokyo, I now have the time to address you, my fans and the media in regard to the upcoming event on December 31st that was recently announced. First and foremost, I want it to be clear that I, F...
Post a Comment
Read more